Juvenile diabetes research foundation: Mission, strategy, and priorities

Diabetes

Volumn 61, Issue 1, 2012, Pages 30-35

  Insel, Richard A ^a   Deecher, Darlene C ^a   Brewer, Jeffrey ^a  

^a Juvenile Diabetes Research Foundation International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ARTIFICIAL PANCREAS; AUTOIMMUNITY; BLOOD GLUCOSE MONITORING; HUMAN; IMMUNIZATION; IMMUNOREGULATION; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INTERNATIONAL COOPERATION; JUVENILE DIABETES MELLITUS; MEDICAL RESEARCH; PANCREAS ISLET BETA CELL; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SECONDARY PREVENTION;

DIABETES MELLITUS, TYPE 1; FINANCING, GOVERNMENT; FOUNDATIONS; GOVERNMENT AGENCIES; HUMANS; MODELS, BIOLOGICAL; PREDIABETIC STATE; RESEARCH;

EID: 84555177980     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1398     Document Type: Review

References (21)

1. Nierras CR, Atkinson MA, Goldstein RA. The Juvenile Diabetes Research Foundation at forty: updates of research in type 1 diabetes. Diabetes 2010;59:1575-1577
2. DIAMOND Project Group. Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet Med 2006;23:857-866
3. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G; EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009;373:2027-2033
4. Harjutsalo V, Sjöberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008;371:1777-1782 (Pubitemid 351697953)
5. Steck AK, Armstrong TK, Babu SR, Eisenbarth GS; Type 1 Diabetes Genetics Consortium. Stepwise or linear decrease in penetrance of type 1 diabetes with lower-risk HLA genotypes over the past 40 years. Diabetes 2011;60:1045-1049
6. Ziegler AG, Nepom GT. Prediction and pathogenesis in type 1 diabetes. Immunity 2010;32:468-478
7. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001;358:221-229 (Pubitemid 32718550)
8. Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010;464:1293-1300
9. Skyler JS, Ricordi C. Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man. Diabetes 2011;60:1-8
10. Atkinson MA, Bluestone JA, Eisenbarth GS, et al. How does type 1 diabetes develop? The notion of homicide or b-cell suicide revisited. Diabetes 2011;60:1370-1379
11. Paris CA, Imperatore G, Klingensmith G, et al. Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: the SEARCH for Diabetes in Youth study. J Pediatr 2009;155:183-189, e1
12. Mortensen HB, Hougaard P; The Hvidøre Study Group on Childhood Diabetes. Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. Diabetes Care 1997;20:714-720 (Pubitemid 27202518)
13. Tamborlane WV, Beck RW, Bode BW, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476
14. Kowalski AJ. Can we really close the loop and how soon? Accelerating the availability of an artificial pancreas: a roadmap to better diabetes outcomes. Diabetes Technol Ther 2009;11(Suppl. 1):S113-S119
15. Kowalski A, Lum JW. Juvenile diabetes research foundation artificial pancreas consortium update. J Diabetes Sci Tech 2009;3:1224-1226
16. Sun JK, Keenan HA, Cavallerano JD, et al. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the Joslin 50-Year Medalist Study. Diabetes Care 2011;34:968-974
17. Robertson RP. Islet transplantation a decade later and strategies for filling a half-full glass. Diabetes 2010;59:1285-1291
18. Vendrame F, Pileggi A, Laughlin E, et al. Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 2010;59:947-957
19. Tian J, Kaufman DL. Antigen-based therapy for the treatment of type 1 diabetes. Diabetes 2009;58:1939-1946
20. Peakman M, von Herrath M. Antigen-specific immunotherapy for type 1 diabetes: maximizing the potential. Diabetes 2010;59:2087-2093
21. Luo X, Herold KC, Miller SD. Immunotherapy of type 1 diabetes: where are we and where should we be going? Immunity 2010;32:488-499